Introduction
============

Alzheimer's disease (AD) is the most common neurodegenerative disease in the elderly ([@B9]; [@B27], [@B33]). Until now, it is still largely unknown about the exact AD genes ([@B12]). In recent years, multiple large-scale genome-wide association studies (GWAS) have been performed, and successfully identified common AD genes including CR1, BIN1, CLU, PICALM, MS4A4/MS4A6E, CD2AP, CD33, EPHA1, ABCA7, SORL1, HLA-DRB5/DRB1, PTK2B, SLC24A4-0RING3, DSG2, INPP5D, MEF2C, NME8, ZCWPW1, CELF1, FERMT2, and CASS4 ([@B6]; [@B7]; [@B34]; [@B18]; [@B26]; [@B20]; [@B15]; [@B38]). Importantly, some of these genes have been successfully validated ([@B24], [@B30],[@B31],[@B32], [@B25],[@B26],[@B28], [@B21], [@B27],[@B29]; [@B18]; [@B2]; [@B3]; [@B19]; [@B37]; [@B41]; [@B45]; [@B20]; [@B22]; [@B44]; [@B12]; [@B15]; [@B38]). In addition, multiple pathway analyses of AD GWAS have been conducted, and provided strong support for immune pathways in AD ([@B8]; [@B13]; [@B17]; [@B24]). [@B43] performed a genetic association study to evaluate the genetic overlap between AD and seven immune-mediated diseases including Crohn's disease, ulcerative colitis, rheumatoid arthritis (RA), type 1 diabetes, celiac disease, and psoriasis ([@B11]; [@B43]). They identified eight genetic variants associated with both AD and immune-mediated diseases ([@B11]; [@B43]). However, epidemiological studies have reported a controversial inverse relationship between AD and RA ([@B5]; [@B16]; [@B39]).

Mendelian randomization could determine the causal inferences, and has been used to evaluate the association between RA and AD ([@B36]; [@B1]). [@B36] selected 62 RA SNPs (*P* \< 5.00E-08, a genome-wide significance level) as instrumental variables, and identified no evidence of a causal association between RA and AD. [@B1] selected 80 RA SNPs as instrumental variables. They selected three methods including IVW, weighted median, and MR-Egger ([@B1]). Both the IVW (beta = −0.039, *P* = 0.021) and weighted median (beta = −0.078, *P* = 0.001) indicated significant association of RA with AD ([@B1]). In summary, both studies evaluated the causal association of RA with AD, and reported inconsistent findings ([@B36]; [@B1]). Importantly, both studies did not evaluate the causal association of AD with RA. Until now, it is still unclear whether AD is a causally associated with RA. Here, we performed a Mendelian randomization study to investigate the causal association of AD with RA.

Materials and Methods {#s1}
=====================

AD GWAS Dataset
---------------

The instrumental variables are AD variants at a genome-wide significance level *P* \< 5.00E-08 identified by previous GWAS. The AD GWAS dataset is from the International Genomics of Alzheimer's Project (IGAP) ([@B18]). In stage 1, the IGAP analyzed a total of 17,008 AD cases and 37,154 controls of European descent (The European Alzheimer's disease Initiative -- EADI, the Alzheimer Disease Genetics Consortium -- ADGC, The Cohorts for Heart and Aging Research in Genomic Epidemiology consortium -- CHARGE, The Genetic and Environmental Risk in AD consortium -- GERAD) ([@B18]). In stage 2, IGAP analyzed additional independent 8,572 AD cases and 11,312 controls ([@B18]). Here, we aimed to selected the independent AD variants at a genome-wide significance level *P* \< 5.00E-08 in this AD dataset ([@B18]).

RA GWAS Dataset
---------------

The RA GWAS dataset is from a previous RA GWAS meta-analysis in a total of \>100,000 subjects of European and Asian ancestries (29,880 RA cases and 73,758 controls) ([@B35]). The summary statistics of RA GWAS meta-analysis included trans-ethnic RA GWAS meta-analysis (19,234 RA cases and 61,565 controls), European RA GWAS meta-analysis (14,361 RA cases and 43,923 controls), and Asian RA GWAS meta-analysis (4,873 RA cases and 17,642 controls) ([@B35]). Here, we selected the European RA GWAS meta-analysis, as the AD GWAS dataset was also from European samples.

Mendelian Randomization Analysis
--------------------------------

Here, we selected three Mendelian randomization analysis methods including inverse-variance weighted meta-analysis (IVW), weighted median regression and MR-Egger regression, as did in recent studies ([@B1]; [@B10]). In addition, we selected the MR-Egger intercept test to assess the instrumental variable assumptions, and provide a statistical test for the presence of potential pleiotropy ([@B1]; [@B10]). The odds ratio (OR) as well as 95% confidence interval (CI) of RA correspond to the genetically determined increase in AD. Meanwhile, we performed a sensitivity analysis using a leave-one-out permutation. All analyses were conducted using the R package "MendelianRandomization" ([@B42]). The significance level for significant association of AD with RA was *P* \< 0.05.

Results
=======

Association of AD Variants With RA
----------------------------------

The meta-analysis of stage 1 and stage 2 in IGAP identified 21 independent AD variants at the genome-wide significance level *P* \< 5.00E-08. Of the 21 AD risk variants, we extracted the summary statistics of 20 variants in RA GWAS. Only one variant rs10745742 and its proxy variants with *r*^2^ \> = 0.8 in HaploReg v4.1 in 1000 Genomes Project (CEU) ([@B40]), were not available in RA GWAS dataset. Hence, our analysis will focus on these 20 variants. Here, we provided more detailed information about these 20 variants in **Table [1](#T1){ref-type="table"}**.

###### 

Characteristics of 20 genetic variants in RA and AD GWAS datasets.

  SNP          Chromosome   Position    Effect allele   Non-effect allele   AD GWAS   RA GWAS                                      
  ------------ ------------ ----------- --------------- ------------------- --------- --------- ---------- --------- ------------- -------
  rs6656401    1            207692049   A               G                   0.1667    0.0165    5.69E-24   −0.0109   0.020625535   0.46
  rs6733839    2            127892810   T               C                   0.1965    0.0141    6.94E-44   0.0237    0.022413611   0.27
  rs35349669   2            234068476   T               C                   0.0755    0.0136    3.17E-08   −0.021    0.020836232   0.25
  rs190982     5            88223420    G               A                   −0.0759   0.0137    3.23E-08   −0.0237   0.022413611   0.26
  rs10948363   6            47487762    G               A                   0.0954    0.0145    5.20E-11   −0.0044   0.01777549    0.67
  rs2718058    7            37841534    G               A                   −0.0774   0.0132    4.76E-09   0.0313    0.021051282   0.091
  rs1476679    7            100004446   C               T                   −0.0891   0.0144    5.58E-10   −0.0381   0.024547967   0.12
  rs11771145   7            143110762   A               G                   −0.102    0.0137    1.12E-13   −0.0113   0.025789826   0.65
  rs28834970   8            27195121    C               T                   0.0959    0.0162    3.27E-09   0.0008    0.020419058   0.84
  rs9331896    8            27467686    C               T                   −0.146    0.0141    2.77E-25   0.0309    0.015784542   0.058
  rs10838725   11           47557871    C               T                   0.0789    0.0138    1.12E-08   −0.0237   0.022413611   0.34
  rs983392     11           59923508    G               A                   −0.1081   0.0134    6.14E-16   0.0313    0.021051282   0.15
  rs10792832   11           85867875    A               G                   −0.14     0.0133    9.32E-26   −0.0005   0.015310717   0.98
  rs11218343   11           121435587   C               T                   −0.2697   0.041     4.98E-11   0.0152    0.051712121   0.74
  rs17125944   14           53400629    C               T                   0.1323    0.0229    7.95E-09   −0.0561   0.033741829   0.097
  rs10498633   14           92926952    T               G                   −0.1044   0.0199    1.47E-07   −0.0264   0.023564622   0.23
  rs8093731    18           29088958    T               C                   −0.6136   0.1123    4.63E-08   −0.002    0.094043657   0.98
  rs4147929    19           1063443     A               G                   0.143     0.0178    1.06E-15   −0.0221   0.031276103   0.48
  rs3865444    19           51727962    A               C                   −0.0667   0.0143    2.97E-06   −0.0109   0.020625535   0.61
  rs7274581    20           55018260    C               T                   −0.1323   0.0237    2.46E-08   0.0331    0.036882967   0.4

Beta is the overall estimated effect size for the effect allele, beta = ln(odd ratio); Beta \> 0 and Beta \< 0 means that this effect allele could increase and reduce disease risk, respectively.

Association of AD With RA
-------------------------

In brief, we did not identify any significant association of AD with RA including the IVW (OR = 0.95, 95% CI: 0.88--1.03, *P* = 0.451), weighted median (OR = 0.96, 95% CI: 0.85--1.07, *P* = 0.217), and MR-Egger (OR = 0.98, 95% CI: 0.78--1.22, *P* = 0.827). In addition, MR-Egger intercept test did not show significant pleiotropy (MR-Egger intercept β = −0.003; *P* = 0.804). Hence, the estimates from these methods were consistent in terms of direction and magnitude. The leave-one-out permutation analysis showed that the direction and precision of the genetic estimates between AD and RA remained largely unchanged. **Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}** shows the individual causal estimates from each of the 20 genetic variants using different methods.

Discussion
==========

Observational studies have evaluated the association between AD and RA. However, these studies reported inconsistent findings. [@B4] conducted a nested case-control study by analyzing more than 8.5 million commercially insured adults. They found that AD was more prevalent among RA patients compared with those without RA ([@B4]). RA population had an increased AD risk ([@B4]). [@B16] performed a case-control study to evaluate the relationship between prior RA and AD using 2271 patients with AD as cases and 6813 patients without AD as controls. They found an inverse association between prior RA and AD ([@B16]). [@B39] conducted a systematic review and meta-analysis of three cohort studies and two cross-sectional studies. They identified significant increased risk of dementia in RA cases ([@B39]). [@B36] a systematic review and meta-analysis of eight case-control and two population-based studies. They found that RA was associated with lower AD incidence ([@B36]).

Genetic association studies also have evaluated the association between AD and immune pathways. These findings are consistent. Several pathway analyses of AD GWAS dataset have identified some immune pathways in AD, including Natural killer cell mediated cytotoxicity (hsa04650), Antigen processing and presentation (hsa04612), retinoic acid-inducible gene-I (RIG-I)-like receptor signaling (hsa04622), asthma (hsa05310), hematopoietic cell lineage (hsa04640), graft-versus-host disease (hsa05332), allograft rejection (hsa05330), autoimmune thyroid disease (hsa05320), and type I diabetes mellitus (hsa04940) ([@B8]; [@B13]; [@B17]; [@B24]). [@B43] found genetic overlap between AD and immune-mediated diseases ([@B11]).

Until now, two Mendelian randomization studies have also been performed to evaluate the association between RA and AD ([@B36]; [@B1]). However, these two studies reported inconsistent findings. [@B36] reported no evidence of a causal association between RA and AD. [@B1] identified a significant causal association of RA with AD. [@B14] found that antirheumatic drugs had protective effect on dementia in RA patients. The classical disease-modifying antirheumatic drug (cDMARDs) users, especially the methotrexate users, had a reduced dementia risk ([@B14]).

In summary, AD and RA are the most common neurodegenerative disease and a chronic autoimmune disease, respectively ([@B23]). Until now, observational studies, genetic association studies, and Mendelian randomization studies have reported inconsistent association between AD and RA. Here, we conducted a Mendelian randomization study to investigate the causal association of AD with RA. We did not identify any significant association of AD with RA.

Our Mendelian randomization study may have several strengths. First, we selected large-scale AD GWAS dataset (74,046 individuals) and RA GWAS dataset (58,284 individuals) from the European descent. This could reduce the influence of the population stratification. Second, the instruments consisted of 20 independent AD genetic variants, which could reduce the influence on of linkage disequilibrium. Third, we selected three Mendelian randomization methods, as did in recent studies.
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Causal estimates from single genetic variant using different Mendelian randomization analysis methods.

###### 

Click here for additional data file.
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